Literature DB >> 8241457

Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

J Olesen1, H K Iversen, L L Thomsen.   

Abstract

Nitroglycerin, which may be regarded as a prodrug for nitric oxide, induces a mild to moderate headache in healthy subjects. In order to study whether migraine patients are more sensitive to nitric oxide than non-migrainous subjects, four different doses of intravenous nitroglycerin were given in a double blind design to 17 migraine patients, 17 age and sex matched healthy controls and 9 subjects with tension-type headache. The nitroglycerin-induced headache was significantly more severe in migraine sufferers, lasted longer and fulfilled diagnostic criteria for migraine more often. We have previously shown a similar supersensitivity to histamine which in human cerebral arteries activates endothelial H1 receptors and causes endothelial production of nitric oxide. Migraine patients are thus supersensitive to exogenous nitric oxide from nitroglycerin as well as to endothelially produced nitric oxide. It is suggested that nitric oxide may be partially or completely responsible for migraine pain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241457     DOI: 10.1097/00001756-199308000-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  66 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

2.  Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.

Authors:  Jamie Bellamy; Elizabeth J Bowen; Andrew F Russo; Paul L Durham
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

3.  Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.

Authors:  Amanda Avona; Carolina Burgos-Vega; Michael D Burton; Armen N Akopian; Theodore J Price; Gregory Dussor
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

Review 4.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

5.  Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

Authors:  Milena De Felice; Michael H Ossipov; Ruizhong Wang; Gregory Dussor; Josephine Lai; Ian D Meng; Juliana Chichorro; John S Andrews; Suman Rakhit; Shawn Maddaford; David Dodick; Frank Porreca
Journal:  Brain       Date:  2010-07-13       Impact factor: 13.501

Review 6.  Nitric oxide-related drug targets in headache.

Authors:  Jes Olesen
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 7.  Thunderclap headache attributed to reversible cerebral vasoconstriction: view and review.

Authors:  Marcelo M Valença; Luciana P A Andrade-Valença; Carlos A Bordini; José Geraldo Speciali
Journal:  J Headache Pain       Date:  2008-07-31       Impact factor: 7.277

8.  Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects.

Authors:  Ravi Gupta; Vivek Kumar; Kalpana Luthra; Basudeb Banerjee; Manjeet Singh Bhatia
Journal:  J Headache Pain       Date:  2009-01-31       Impact factor: 7.277

Review 9.  Migraine: where and how does the pain originate?

Authors:  Karl Messlinger
Journal:  Exp Brain Res       Date:  2009-03-14       Impact factor: 1.972

Review 10.  Cerebral hemodynamics in the different phases of migraine and cluster headache.

Authors:  Jakob M Hansen; Christoph J Schankin
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.